Further investigations of the immune cells and macrophages in two meningiomas revealed expression of the immune checkpoint inhibitor TIM-3 and CD83, an activation marker of M1 macrophages (Figure 4 and Supplementary Figure S4). The gene discussed is HAVCR2; the disease is meningioma.